Pharmacological approaches to the treatment of combined functional pathology (biliary and intestinal tract)

Pharmacological approaches to the treatment of combined functional pathology (biliary and intestinal tract)

The article presents data on a new classification of functional disorders according to Rome IV criteria. Particular attention is given to the combined functional pathology - the overlap syndrome. The combination of functional biliary disorders (PBD) and irritable bowel syndrome (IBS) is the most com...

Full description

Bibliographic Details
Main Author:	O. N. Minushkin
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2018-10-01
Series:	Медицинский совет
Subjects:	overlap syndrome functional biliary disorders irritable bowel syndrome treatment antispasmodic drugs
Online Access:	https://www.med-sovet.pro/jour/article/view/2656

Similar Items

The Role of Motility Impairment in the Pathogenesis of Functional Disorders of the Gastrointestinal Tract and Modern Possibilities for Their Treatment (Resolution of an Expert Council and Literature Review)
by: I. V. Maev, et al.
Published: (2020-01-01)

Irritable bowel syndrome and biliary tract pathology. Clinical analysis
by: T. E. Polunina
Published: (2020-10-01)

Acupuncture vs. antispasmodics in the treatment of irritable bowel syndrome: An adjusted indirect treatment comparison meta-analysis
by: Yun-zhou Shi, et al.
Published: (2022-10-01)

Features of the motor function of the gastrointestinal tract at the cross-functional pathology
by: Alla E. Lychkova, et al.
Published: (2023-08-01)

Functional disorders of the biliary tract: modern diagnostic criteria and principles of pharmacotherapy
by: D. T. Dicheva, et al.
Published: (2020-08-01)

Pathogenetic approach to the treatment of functional disorders of the gastrointestinal tract and their intersection: results of the Russian observation retrospective program COMFORT
by: Vladimir T. Ivashkin, et al.
Published: (2019-12-01)

The biliary continuum: an up-to-date look at biliary tract diseases
by: I. V. Maev, et al.
Published: (2021-10-01)

Role of antispasmodics in the treatment of irritable bowel syndrome
by: V. N. Drozdov, et al.
Published: (2021-05-01)

Rational pharmacotherapy in modern gastroenterology
by: O. N. Minushkin
Published: (2021-10-01)

Prevalence of combination of functional dyspepsia and irritable bowel syndrome: a meta-analysis of studies using the Rome III–IV Criteria
by: Dmitry N. Andreev, et al.
Published: (2022-10-01)

Modern aspects of the management of patients with irritable bowel syndrome
by: V. V. Tsukanov, et al.
Published: (2021-05-01)

Overlap of functional dyspepsia and irritable bowel syndrome by revised Rome IV criteria: meta-analysis
by: I. V. Maev, et al.
Published: (2021-05-01)

Biliary slage as a stage of gallstone disease: the successes and difficulties of treatment
by: O. N. Minushkin, et al.
Published: (2021-01-01)

Irritable Bowel Syndrome: Role of Intestinal Microbiota Disorders and Ways of Their Correction
by: I.Ya. Budzak
Published: (2013-09-01)

Combined functional disorders (diseases) of the gastrointestinal tract. Diagnostic and treatment approaches
by: O. N. Minushkin
Published: (2015-12-01)

Irritable bowel syndrome: current aspects of etiology, pathogenesis, clinic and treatment: A review
by: Dmitry I. Trukhan, et al.
Published: (2022-07-01)

Pathological syndromes of the biliary tract decompression
by: Rasul T. Mejidov, et al.
Published: (2021-10-01)

Gastrointestinal Endometriosis Causing Subacute Intestinal Obstruction with Gradual Development of Weight Loss and Misdiagnosed as Irritable Bowel Syndrome
by: Amir Soumekh, et al.
Published: (2014-01-01)

Shared genetic architecture between irritable bowel syndrome and psychiatric disorders reveals molecular pathways of the gut-brain axis
by: Markos Tesfaye, et al.
Published: (2023-08-01)

Prognostic indicators in primary biliary cirrhosis: significance of revised IAHG (International Autoimmune Hepatitis Group) score
by: Ho Eun Jung, et al.
Published: (2012-12-01)

Efficacy of trimebutine in the treatment of functional gastrointestinal disorders: an observational multicenter study
by: Dmitry N. Andreev, et al.
Published: (2021-08-01)

Irritable Bowel Syndrome: The role of the Psychiatry
by: A. Fraga, et al.
Published: (2022-06-01)

Non-pharmacologic approaches to treatment of pediatric functional abdominal pain disorders
by: Partha Sarathi Chakraborty, et al.
Published: (2023-06-01)

Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
by: Mohammad Alomari, et al.
Published: (2020-04-01)

Effect of antispasmodic agents, alone or in combination, in the treatment of Irritable Bowel Syndrome: Systematic review and meta-analysis
by: M.A. Martínez-Vázquez, et al.
Published: (2012-04-01)

Development of theory on intestinal dysfunction in the XXI century
by: Asfol'd Ivanovich Papfenov, et al.
Published: (2009-02-01)

Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes
by: Yoonsang Park, et al.
Published: (2015-06-01)

Irritable bowel syndrome and inflammatory bowel disease overlap syndrome: pieces of the puzzle are falling into place
by: Rafiz Abdul Rani, et al.
Published: (2016-10-01)

Migraine and Irritable Bowel Syndrome: an Epidemiological Study
by: Samira Mirzaei, et al.
Published: (2016-03-01)

Use of Rifaximin in Irritable Bowel Syndrome Treatment
by: Hubert Wróblewski, et al.
Published: (2021-08-01)

Validity and reliability of the Japanese versions of cognitive and behavioral scales for irritable bowel syndrome
by: Nagisa Sugaya, et al.
Published: (2022-07-01)

Frequency of Different Psychiatric Disorders in Patients With Functional Bowel Disorders: A Short Report
by: Bahareh Fakhraei, et al.
Published: (2015-06-01)

Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms
by: Claudia Di Rosa, et al.
Published: (2023-03-01)

Local esperience on frequency and significance of immunological overlap in the field of primary biliary cirrhosis (PBC)
by: Caterina Defendenti, et al.
Published: (2008-06-01)

Is fecal calprotectin always normal in children with irritable bowel syndrome?
by: You Jin Choi, et al.
Published: (2019-10-01)

TRIMEBUTIN IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME AND OTHER FUNCTIONAL GASTROINTESTINAL DISORDERS
by: D. I. TRUKHAN, et al.
Published: (2016-12-01)

Functional Disorders of the Gastrointestinal Tract During the Pandemic of a New Coronavirus Infection
by: A. A. Sheptulin, et al.
Published: (2022-09-01)

Fructose: role in the formation of intestinal symptoms
by: N.N. Silivontchik
Published: (2022-04-01)

Efficacy of Kolofort for the treatment of patients with irritable bowel syndrome
by: V V Tsukanov, et al.
Published: (2016-08-01)

Intestinal Barrier in Post-<i>Campylobacter jejuni</i> Irritable Bowel Syndrome
by: Sholpan Omarova, et al.
Published: (2023-02-01)